Affiliation:
1. Clinical Institute, Faculty of Veterinary Medicine, Latvia University of Life Sciences and Technologies, Jelgava, Latvia.
Abstract
Background and Aim: Maintaining intraocular pressure (IOP) stability during ophthalmic procedures is essential to ensuring surgical success and reducing complications related to IOP fluctuations. This study aimed to evaluate IOP dynamics in dogs undergoing mild-pain ophthalmic procedures under three different premedication protocols: butorphanol alone (B), butorphanol with medetomidine (BM), and butorphanol with acepromazine (BA).
Materials and Methods: Thirty clinically healthy client-owned dogs of various breeds (19 males, 11 females, aged 4 months–11 years, weight 7.8–79 kg) were randomized into three groups. IOP was measured at multiple perioperative time points using rebound tonometry: premedication (T0), 5 (T5), and 10 (T10) min after premedication, after intubation (Tint), before surgery (Tbsur), post-surgery (Tasur), during extubation (Text), and before discharge (Tlea). Statistical analyses, including t-tests and Pearson correlation, were performed to assess differences in IOP within and between groups.
Results: Significant changes in IOP were observed at different time points across groups. The B group showed a significant IOP increase between T0 (15.55 ± 3.50 mmHg) and Tint (19.3 ± 4.19 mmHg) (p < 0.05). In the BM group, IOP increased from T0 (15.9 ± 2.77 mmHg) to Tint (19.15 ± 4.52 mmHg) and decreased significantly postoperatively at Tasur (13.5 ± 3.50 mmHg). The BA group exhibited significant IOP reductions from T0 (20.35 ± 2.78 mmHg) to Tbsur (16.45 ± 3.97 mmHg) and Tlea (17.15 ± 4.22 mmHg). No correlation was found between IOP and sex, breed, or age.
Conclusion: IOP remained within normal ranges throughout the perioperative period in all groups. Acepromazine, in combination with butorphanol, was the most effective in attenuating the IOP increase caused by intubation, suggesting its potential advantage in patients at risk of corneal perforation. Clinically, premedication selection should prioritize minimal IOP fluctuation to enhance surgical outcomes.
Keywords: acepromazine, butorphanol, dog, intraocular pressure, medetomidine, premedication.
Reference54 articles.
1. Kusolphat, P., Soimala, T. and Sunghan, J. (2022) Intraocular pressure and cardiovascular effects of dexmedetomidine premedication and tiletamine-zolazepam for anesthetic induction in dogs. Vet. World, 15(12): 2929–2936.
2. Lerche, P. (2021) Anesthesia for ophthalmic patients. In: Johnson, R.A., Lindsey, B., Snyder, L. and Schroeder, C., editors. Canine and Feline Anesthesia and Co‐Existing Disease. 2nd ed. John Wiley and Sons, Inc., United States, p359–372.
3. Pierce-Tomlin, T., Shaughnessy, M.R. and Hofmeister, E.H. (2020) A systematic review of the effects of injectable sedative and anesthetic drugs and inhalant anesthetics on intraocular pressure in the dog. Vet. Anaesth. Analg., 47(2): 145–151.
4. Directive 2010/63/EU of the European Parliament and of the Council of 22 September 2010 on the Protection of Animals Used for Scientific Purposes Text with EEA Relevance. Available from: https://eur-lex.europa.eu/eli/dir/2010/63/oj. Retrieved on 04-06-2024.
5. Monteiro, B.P., Lascelles, B.D.X. and Murrell, J. (2022) WSAVA guidelines for the recognition, assessment and treatment of pain. J. Small. Anim. Pract., 64(4): 177–254.